John C. Waterton, Ph.D., AstraZeneca, Cheshire, England, UK
Martin O. Leach, Ph.D., Institute of Cancer Research, England, UK
MR in Drug Research Study Group
Tuesday, 21 May 2002
Room 315
19:30 - 21:30
| Business Meeting | |
| Scientific Meeting | |
|
How MRI Helps the Drug Industry
Discover and Develop More Valuable Medicines Faster John C. Waterton, Ph.D., AstraZeneca, Cheshire, England, UK |
|
What's Needed for DCEMRI in Trials
of Drugs Targeted at the Vasculature Martin O. Leach, Ph.D., Institute of Cancer Research, England, UK |
|
Discussion Period |